Novo A/S Acquires Xellia Pharmaceuticals for US$ 700 million

News   May 21, 2013

 
Novo A/S Acquires Xellia Pharmaceuticals for US$ 700 million
 
 
 

RELATED ARTICLES

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE

Ingenza Advances inABLE® Biomanufacturing Technologies in Collaboration with Syngenta

News

Ingenza has reached a major technical milestone with Syngenta in their collaboration to develop efficient manufacturing technologies for innovative crop protection products.

READ MORE


 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE